Copley Acquisition and Ignite Proteomics terminate business combination agreement

COPL•2026-10-13

Copley Acquisition Corp and Ignite Proteomics mutually terminated their business combination agreement effective October 9, 2026, ending all rights and obligations under it except certain sections.

1. Agreement terminated

Copley Acquisition Corp and Ignite Proteomics mutually terminated their business combination agreement effective October 9, 2026. A termination agreement ends all rights and obligations under the business combination agreement except certain sections.

Sources

Copley Acquisition terminates Ignite Proteomics business combination agreement

Sec

Copley Acquisition and Ignite Proteomics terminate business combination agreement

1. Agreement terminated

Related News

Sharplink director Joseph Lubin reports sale of 5,676,952 shares worth $47.63 million

Vivek Ramaswamy reports 5.6% stake in Strive as of Oct. 6, down from 6.6% on Aug. 24

Hinge Health co-founder Gabriel M.I. Mecklenburg sells $20.26 million in Class A shares

Sources

Copley Acquisition terminates Ignite Proteomics business combination agreement

RPM director Julie Beck receives 1,700-share award under 2024 omnibus equity plan

World stocks dip on AI spending concerns; Brent settles lower